The stock of Organon & Co (NYSE:OGN) last traded at $15.80, down -4.01% from the previous session.
OGN stock price is now -16.90% away from the 50-day moving average and -18.31% away from the 200-day moving average. The market capitalization of the company currently stands at $4.07B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target enhanced from $18 to $20, JP Morgan Downgraded its rating from Neutral to Underweight for Organon & Co (NYSE: OGN). On November 03, 2023, Goldman Downgraded its previous ‘Buy’ rating to ‘Neutral’ on the stock reducing its target price from $33 to quote $16, while ‘Barclays’ rates the stock as ‘Overweight’
In other news, Weaver Kirke, Gen. Counsel & Corp. Secy. bought 2,720 shares of the company’s stock on Feb 22 ’24. The stock was bought for $49,939 at an average price of $18.36. Upon completion of the transaction, the Gen. Counsel & Corp. Secy. now directly owns 15,181 shares in the company, valued at $0.24 million. A total of 0.22% of the company’s stock is owned by insiders.
During the past 12 months, Organon & Co has had a low of $10.84 and a high of $23.10. As of last week, the company has a debt-to-equity ratio of 17.75, a current ratio of 1.70, and a quick ratio of 1.21. According to the stock market information, the enterprise value for the company is $12055113728, which is based on a 3.13 price-to-earnings ratio, a 0.65 price-to-earnings-growth ratio, and a beta of 0.79. The fifty day moving average price for OGN is $19.1444 and a two-hundred day moving average price translates $19.3426 for the stock.
The latest earnings results from Organon & Co (NYSE: OGN) was released for 2024-09-30. The company reported revenue of $1.58 billion for the quarter, compared to $1.52 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 4.15 percent.
